165 related articles for article (PubMed ID: 35777481)
1. Hepatocellular Carcinoma Risk Declines but Remains High Enough for Screening in the First 7 Years After Hepatitis C Virus Cure With Direct-Acting Antivirals in Patients With Cirrhosis or High Fibrosis-4 Score.
Kim NJ; Vutien P; Berry K; Ioannou GN
Gastroenterology; 2022 Oct; 163(4):1104-1106.e3. PubMed ID: 35777481
[No Abstract] [Full Text] [Related]
2. Duration and cost-effectiveness of hepatocellular carcinoma surveillance in hepatitis C patients after viral eradication.
Mueller PP; Chen Q; Ayer T; Nemutlu GS; Hajjar A; Bethea ED; Peters MLB; Lee BP; Janjua NZ; Kanwal F; Chhatwal J
J Hepatol; 2022 Jul; 77(1):55-62. PubMed ID: 35157959
[TBL] [Abstract][Full Text] [Related]
3. [Residual risk of liver disease after hepatitis C virus eradication].
Ongaro M; Mathys P; Zampaglione L; Negro F
Rev Med Suisse; 2021 Sep; 17(748):1453-1456. PubMed ID: 34468096
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal Associations of Risk Factors and Hepatocellular Carcinoma in Patients With Cured Hepatitis C Virus Infection.
Kramer JR; Cao Y; Li L; Smith D; Chhatwal J; El-Serag HB; Kanwal F
Am J Gastroenterol; 2022 Nov; 117(11):1834-1844. PubMed ID: 36327437
[TBL] [Abstract][Full Text] [Related]
5. Reply to: 'Risk stratification of hepatocellular carcinoma after hepatitis C virus eradication in patients with compensated advanced chronic liver disease in Japan'.
Semmler G; Mandorfer M
J Hepatol; 2022 Aug; 77(2):571-572. PubMed ID: 35526785
[No Abstract] [Full Text] [Related]
6. Inflammatory patterns in plasma associate with hepatocellular carcinoma development in cured hepatitis C cirrhotic patients.
Owusu Sekyere S; Port K; Deterding K; Cornberg M; Wedemeyer H
United European Gastroenterol J; 2021 May; 9(4):486-496. PubMed ID: 33349201
[TBL] [Abstract][Full Text] [Related]
7. Risk of hepatocellular carcinoma after hepatitis C virus cure.
Luna-Cuadros MA; Chen HW; Hanif H; Ali MJ; Khan MM; Lau DT
World J Gastroenterol; 2022 Jan; 28(1):96-107. PubMed ID: 35125821
[TBL] [Abstract][Full Text] [Related]
8. Fibrosis Stage-specific Incidence of Hepatocellular Cancer After Hepatitis C Cure With Direct-acting Antivirals: A Systematic Review and Meta-analysis.
Kim NJ; Vutien P; Cleveland E; Cravero A; Ioannou GN
Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1723-1738.e5. PubMed ID: 35525392
[TBL] [Abstract][Full Text] [Related]
9. Unmet Needs in the Post-Direct-Acting Antiviral Era: Hepatocarcinogenesis After Hepatitis C Virus Eradication.
Przybyszewski EM; Chung RT
J Infect Dis; 2023 Sep; 228(Suppl 3):S226-S231. PubMed ID: 37703341
[TBL] [Abstract][Full Text] [Related]
10. Should we continue surveillance for hepatocellular carcinoma and gastroesophageal varices in patients with cirrhosis and cured HCV infection?
Isfordink CJ; Maan R; de Man RA; van Erpecum KJ; van der Meer AJ
Eur J Intern Med; 2021 Dec; 94():6-14. PubMed ID: 34563447
[TBL] [Abstract][Full Text] [Related]
11. [Risk of hepatocellular carcinoma after hepatitis C virus cure with direct-acting antivirals: the next challenges].
Hamdane N; Baumert TF; Zeisel MB
Med Sci (Paris); 2018 May; 34(5):391-394. PubMed ID: 29900836
[No Abstract] [Full Text] [Related]
12. Increased incidence or recurrence of hepatocellular carcinoma in hepatitis C virus cirrhotic patients treated with direct-acting antivirals: myth or fact?
Maida M; Cabibbo G; Cammà C
Expert Rev Anticancer Ther; 2018 Apr; 18(4):307-309. PubMed ID: 29466888
[No Abstract] [Full Text] [Related]
13. Hepatocellular carcinoma risk after viral response in hepatitis C virus-advanced fibrosis: Who to screen and for how long?
Ahumada A; Rayón L; Usón C; Bañares R; Alonso Lopez S
World J Gastroenterol; 2021 Oct; 27(40):6737-6749. PubMed ID: 34790004
[TBL] [Abstract][Full Text] [Related]
14. Risk stratification of hepatocellular carcinoma after hepatitis C virus eradication in patients with compensated advanced chronic liver disease in Japan.
Nakatsuka T; Tateishi R; Nakagomi R; Minami T; Koike K
J Hepatol; 2022 Aug; 77(2):569-571. PubMed ID: 35288188
[No Abstract] [Full Text] [Related]
15. Comparison of acknowledged hepatocellular carcinoma risk scores in high-risk hepatitis C patients with sustained virological response.
Qiu L; Xu S; Qiu Y; Liu Y; Zhang J
J Viral Hepat; 2023 Jun; 30(6):559-566. PubMed ID: 36890735
[TBL] [Abstract][Full Text] [Related]
16. Detection of hepatocellular cancer during screening of 1125 patients with chronic hepatitis virus infection.
Izzo F; Cremona F; Ruffolo F; Palaia R; Parisi V; Curley S
J Chemother; 1997 Apr; 9(2):151-2. PubMed ID: 9176768
[No Abstract] [Full Text] [Related]
17. Hepatocellular carcinoma incidence post direct-acting antivirals in hepatitis C-related advanced fibrosis/cirrhosis patients in Australia.
Chan PPY; Levy MT; Shackel N; Davison SA; Prakoso E
Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):541-546. PubMed ID: 32660841
[TBL] [Abstract][Full Text] [Related]
18. Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients.
Cabibbo G; Celsa C; Calvaruso V; Petta S; Cacciola I; Cannavò MR; Madonia S; Rossi M; Magro B; Rini F; Distefano M; Larocca L; Prestileo T; Malizia G; Bertino G; Benanti F; Licata A; Scalisi I; Mazzola G; Di Rosolini MA; Alaimo G; Averna A; Cartabellotta F; Alessi N; Guastella S; Russello M; Scifo G; Squadrito G; Raimondo G; Trevisani F; Craxì A; Di Marco V; Cammà C;
J Hepatol; 2019 Aug; 71(2):265-273. PubMed ID: 30959157
[TBL] [Abstract][Full Text] [Related]
19. GES: A validated simple score to predict the risk of HCC in patients with HCV-GT4-associated advanced liver fibrosis after oral antivirals.
Shiha G; Waked I; Soliman R; Elbasiony M; Gomaa A; Mikhail NNH; Eslam M
Liver Int; 2020 Nov; 40(11):2828-2833. PubMed ID: 32946647
[TBL] [Abstract][Full Text] [Related]
20. Risk of hepatocellular carcinoma and fibrosis evolution in hepatitis C patients with severe fibrosis or cirrhosis treated with direct acting antiviral agents.
Hamoir C; Horsmans Y; Stärkel P; Dahlqvist G; Negrin Dastis S; Lanthier N
Acta Gastroenterol Belg; 2021; 84(1):25-32. PubMed ID: 33639690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
